Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells. | Bioengineered | 2022 | 34818980 | PubTator, text mining | PubMed |
| Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma. | Clin Mol Hepatol | 2022 | 34665953 | PubTator, text mining | PubMed |
| Epigenetic regulation of immunosuppressive tumor-associated macrophages through dysregulated microRNAs. | Semin Cell Dev Biol | 2022 | 34556420 | PubTator, text mining | PubMed |
| The immunogenomic landscape of resected intrahepatic cholangiocarcinoma. | Hepatology | 2022 | 34510503 | PubTator, text mining | PubMed |
| Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic. | Chembiochem | 2022 | 34494353 | PubTator, text mining | PubMed |
| Single cell multiomic analysis of T cell exhaustion in vitro. | Cytometry A | 2022 | 34390166 | PubTator, text mining | PubMed |
| Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma. | Cancer Immunol Immunother | 2022 | 34275008 | PubTator, text mining | PubMed |
| Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma. | Dig Dis Sci | 2022 | 33495920 | PubTator, text mining | PubMed |
| Bilateral squamosal synostosis: unusual presentation of chromosome 1p12-1p13.3 deletion. Illustrative case. | J Neurosurg Case Lessons | 2021 | 36034505 | PubTator, text mining | PubMed |
| CD8+ T regulatory cells in lupus. | Rheumatol Immunol Res | 2021 | 35880241 | PubTator, text mining | PubMed |
| Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates. | Front Immunol | 2021 | 35178045 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of VSTM2L in Cancer. | Front Mol Biosci | 2021 | 35155565 | PubTator, text mining | PubMed |
| A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer. | Front Oncol | 2021 | 35155184 | PubTator, text mining | PubMed |
| The Non-N6-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma. | Front Immunol | 2021 | 35154083 | PubTator, text mining | PubMed |
| Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer. | Front Med (Lausanne) | 2021 | 35141255 | PubTator, text mining | PubMed |
| Bioinformatic Analyses of the Ferroptosis-Related lncRNAs Signature for Ovarian Cancer. | Front Mol Biosci | 2021 | 35127813 | PubTator, text mining | PubMed |
| Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival. | Front Med (Lausanne) | 2021 | 35127742 | PubTator, text mining | PubMed |
| EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer. | Front Genet | 2021 | 35126464 | PubTator, text mining | PubMed |
| Immunotherapy and radiation for high-grade glioma: a narrative review. | Transl Cancer Res | 2021 | 35116570 | PubTator, text mining | PubMed |
| Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients. | Front Immunol | 2021 | 35095892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=50